The EMJ Podcast | Episode 149
This episode focuses on approaches toward the World Health Organization (WHO)’s goal for eliminating hepatitis worldwide by 2030, and the importance of reliable information when making informed healthcare decisions. Jonathan is joined by Raymond Chung, Director of the Hepatology and Liver Center at Massachusetts General Hospital, Boston, USA, and Professor of Medicine at Harvard Medical School. The pair discuss technological advances in hepatology, such as the use of living donors in liver transplantation.
Spotify | Apple | Amazon Music | Download MP3 (mp3, 44:42 mins)
Speaker bio:
Raymond Chung is an established Gastroenterologist and Transplant Hepatologist; Director of the Hepatology and Liver Center, Massachusetts General Hospital, Boston, USA; and Professor of Medicine at Harvard Medical School, Boston Massachusetts, USA. Chung completed his first degree at Harvard University, Cambridge, Massachusetts, USA, and went on to gain his medical degree from Yale School of Medicine, New Haven, Connecticut, USA. He has been both a Resident and Clinical Fellow at the Johns Hopkins Hospital in Baltimore, Maryland, USA, and has worked at Massachusetts General Hospital for 20 years. He has won many awards and has held a number of professional positions across his career, including President of the American Association for the Study of Liver Diseases (AASLD). Chung has published almost 600 papers as author or co-author.
